Creating a scalable clinical pharmacogenomics service with automated interpretation and medical record result integration – experience from a pediatric tertiary care facility
- 14 June 2016
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of the American Medical Informatics Association
- Vol. 24 (1) , 74-80
Abstract
Objective: This paper outlines the implementation of a comprehensive clinical pharmacogenomics (PGx) service within a pediatric teaching hospital and the integration of clinical decision support in the electronic health record (EHR). Materials and Methods: An approach to clinical decision support for medication ordering and dispensing driven by documented PGx variant status in an EHR is described. A web-based platform was created to automatically generate a clinical report from either raw assay results or specified diplotypes, able to parse and combine haplotypes into an interpretation for each individual and compared to the reference lab call for accuracy. Results: Clinical decision support rules built within an EHR provided guidance to providers for 31 patients (100%) who had actionable PGx variants and were written for interacting medications. A breakdown of the PGx alerts by practitioner service, and alert response for the initial cohort of patients tested is described. In 90% (355/394) of the cases, thiopurine methyltranferase genotyping was ordered pre-emptively. Discussion: This paper outlines one approach to implementing a clinical PGx service in a pediatric teaching hospital that cares for a heterogeneous patient population. There is a focus on incorporation of PGx clinical decision support rules and a program to standardize report text within the electronic health record with subsequent exploration of clinician behavior in response to the alerts. Conclusion: The incorporation of PGx data at the time of prescribing and dispensing, if done correctly, has the potential to impact the incidence of adverse drug events, a significant cause of morbidity and mortality.Keywords
This publication has 19 references indexed in Scilit:
- Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake InhibitorsClinical Pharmacology & Therapeutics, 2015
- Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and HLA-B Genotypes and Phenytoin DosingClinical Pharmacology & Therapeutics, 2014
- PG4KDS: A model for the clinical implementation of pre‐emptive pharmacogeneticsAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2014
- Development and use of active clinical decision support for preemptive pharmacogenomicsJournal of the American Medical Informatics Association, 2014
- The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Overcoming Challenges of Real-World ImplementationClinical Pharmacology & Therapeutics, 2013
- Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 Genotypes and Warfarin DosingClinical Pharmacology & Therapeutics, 2011
- Pharmacogenetics: From Bench to Byte— An Update of GuidelinesClinical Pharmacology & Therapeutics, 2011
- CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research NetworkClinical Pharmacology & Therapeutics, 2011
- Pharmacogenetics: From Bench to ByteClinical Pharmacology & Therapeutics, 2008
- A Comparison of the Effects of Computer and Manual Reminders on Compliance with a Mental Health Clinical Practice GuidelineJournal of the American Medical Informatics Association, 2000